SCHEMBL6972205

SCHEMBL6972205

COc1ccc2c(c1)c(O)nn2Cc1cccc([N+](=O)[O-])c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
PIK3R1 P27986 1/20 0.53
PIK3CA P42336 1/20 0.53
PLA2G2A P14555 1/20 0.53
CNR2 P34972 4/20 0.48
ACHE P22303 3/20 0.48
CNR1 P21554 2/20 0.48
MGLL Q99685 1/20 0.47
ABHD6 Q9BV23 1/20 0.47
NOX4 Q9NPH5 1/20 0.45
PIK3CD O00329 1/20 0.45
ELANE P08246 2/20 0.45
KMT2A Q03164 1/20 0.43
PTGER4 P35408 1/20 0.43
F2 P00734 1/20 0.43
PLAU P00749 1/20 0.43
CTRB1 P17538 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7805412 0.89 CNR2 (0.57) MAPTSMN1; SMN2CNR2ACHECNR1
SCHEMBL8448901 0.84 ACHE (0.43) MAPTSMN1; SMN2PIK3R1PIK3CAPLA2G2A
SCHEMBL8443748 0.82 PLA2G2A (0.52) MAPTPLA2G2ACNR2CNR1KMT2A
SCHEMBL6973326 0.82 CNR2 (0.58) MAPTSMN1; SMN2PIK3R1PIK3CAPLA2G2A
SCHEMBL8444741 0.80 KCNJ1 (0.53) MAPTSMN1; SMN2PIK3R1PIK3CACNR2
SCHEMBL6969393 0.80 CNR2 (0.64) MAPTSMN1; SMN2PIK3R1PIK3CAPLA2G2A
SCHEMBL8448659 0.80 CNR1 (0.52) MAPTCNR2CNR1KMT2APTGER4
SCHEMBL6979571 0.80 CNR2 (0.56) MAPTSMN1; SMN2PIK3R1PIK3CAPLA2G2A
SCHEMBL6967955 0.80 CNR2 (0.61) MAPTSMN1; SMN2PIK3R1PIK3CAPLA2G2A
Hydrochloric Acid SCHEMBL6971824 0.80 CNR2 (0.63) MAPTSMN1; SMN2PIK3R1PIK3CAPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077947-B1 NOVEL 1,5 AND 3-O-SUBSTITUTED 1H-INDAZOLES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS DRESDEN ARZNEIMITTEL (DE) 2003-09-03 EP disclosed
EP-1077948-A1 NOVEL 1,2,5-TRISUBSTITUTED 1,2-DIHYDRO-INDAZOL-3-ONES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICAMENT ARZNEIMITTELWERK DRESDEN GMBH (DE) 2001-02-28 EP disclosed
EP-1077947-A1 NOVEL 1,5 AND 3-O-SUBSTITUTED 1H-INDAZOLES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS ARZNEIMITTELWERK DRESDEN GMBH (DE) 2001-02-28 EP disclosed
US-6180637-B1 THERAPY FOR PARKINSON, ALZHEIMER DISEASE ARZNEIMITTELWERK DRESDEN GMBH (DE) 2001-01-30 US disclosed
US-6166023-A 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments ARZNEIMITTELWERK DRESDEN GMBH (DE) 2000-12-26 US disclosed
WO-1999058504-A9 NOVEL 1,2,5-TRISUBSTITUTED 1,2-DIHYDRO-INDAZOL-3-ONES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICAMENT DRESDEN ARZNEIMITTEL (DE) 2000-02-03 WO disclosed
WO-1999058503-A1 NOVEL 1,5 AND 3-O-SUBSTITUTED 1H-INDAZOLES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS ARZNEIMITTELWERK DRESDEN GMBH (DE) 1999-11-18 WO disclosed
WO-1999058504-A1 NOVEL 1,2,5-TRISUBSTITUTED 1,2-DIHYDRO-INDAZOL-3-ONES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICAMENT ARZNEIMITTELWERK DRESDEN GMBH (DE) 1999-11-18 WO disclosed